Published in TB and Outbreaks Week, September 13th, 1999
The U.S. Food and Drug Administration (FDA) approved a pneumonia test from Binax Inc., Portland, Maine. It uses a patient's urine to detect a bacterium called Streptococcus pneumoniae, which is estimated to cause 500,000 cases of pneumonia a year.
The test should help doctors decide more quickly if a patient's pneumonia is caused by that bacterium, and thus what treatment is needed.
That's a crucial decision for today's doctors because of a growing army of "supergerms" -...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.